Humanigen announces positive interim Phase 3 Data of Lenzilumab in Covid patients
Humanigen Inc has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with Covid-19.
Humanigen is a clinical stage biopharmaceutical company focused on...
New findings on brain acquiring essential omega-3 fatty acids
Scientists at the National Institutes of Health and colleagues have developed a zebrafish model that provides new insight into how the brain acquires essential...
Happy news on war against Covid-19, Sputnik V vaccine to hit market in affordable...
Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF) has announced the cost of the Sputnik V vaccine for international markets will be less...
Diabeloop launches DBL-hu to manage highly unstable diabetes
Diabeloop said it has received CE marking for its adjustable and innovative technological solution called DBL-hu.
The solution, according Diabeloop, enhances glycemic control and satisfaction...
Piramal Pharma Solutions on expansion mode, invests ~$32 Million
Piramal Pharma Solutions, a Piramal Pharma Limited business and a leading Contract Development and Manufacturing Organization (CDMO), has revealed its plans to expand its...
Obstructive sleep apnea ups risk for long COVID
Among the Covid-19 hit people,, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of long COVID than those without...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...
ChanRe, IARET throws light on Autoimmune diseases in awareness programme
An awareness programme on Autoimmune diseases & Lupus conducted by the Immunology & Arthritis Research & Education Trust (IARET) and ChanRe Rheumatology & Immunity...
REME HALO inactivates levels of SARS-COV-2 by 99.9%: Zeco Aircon Group Study
Zeco in partnership with RGF Environmental group has published the results of a third-party study that claim REME HALO with photo hydro ionisation (PHI)...
Pfizer, Biontech announce vaccine candidate against Covid-19
Pfizer Inc and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against Covid-19 in participants without...